OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

1 Projects | 1 Researchers | $1,820,426 Invested

2022

Molecular Stethoscope, Inc

John Sninsky, PhD

Development of cell free messenger RNA-based non-invasive diagnostic biomarker for Alzheimer's disease

  • Funding Amount: $1,820,426
  • Organization Type: Biotechnology/For Profit
  • Program: Biomarkers
  • Target: Other
  • Status: Active